Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.28B |
| Enterprise Value | 13.24B |
| P/E Ratio | -132.95 |
| PEG Ratio | -9.12 |
| Price/Sales Ratio | 53.89 |
| Price/Book Ratio | 13.57 |
| Enterprise/Revenue | 53.85 |
| Enterprise/EBITDA | -174.47 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.41 |
| Operating Margin | -0.44 |
AD
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.09 |
Income Statement
| Revenue | 220.23M |
| Revenue/Share | 0.43 |
| Gross Profit | 170.15M |
| EBITDA | -55.69M |
| Net Income | -77.76M |
| Diluted EPS | -0.16 |
Balance Sheet
| Total Cash | 128.28M |
| Total Cash/Share | 0.27 |
| Total Debt | 119.78M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2 |
| Book Value Per Share | 1.66 |
Price History
| 52-Week Change | -39.43 |
| 52-Week High | 66.66 |
| 52-Week Low | 19.28 |
| Moving Average 50 Days | 26.37 |
| Moving Average 200 Days | 29.35 |
Statistics
| Average Volume | 35.54M |
| Shares Outstanding | 477.77M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1399:1000 |
| Last Split Date | May 05, 2016 |
AD
